1. Market Research
  2. > Therapy Industry
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Insulin Industry, August 2017 Market Reports from Top Publishers

You might be interested in: Diagnostics, Injectable Delivery, Biosimilar, Diabetes, Diabetes Monitoring, Insulin Delivery, Therapy, Antidiabetics, Cancer, Catheter, Biopharmaceutical, Pharmaceutical, Medical Equipment, Transdermal Delivery, Diabetes Care, Home Healthcare, Infectious Disease, Type 2 Diabetes, Cancer Diagnostic, Construction.


 
1-10 of about 300 reports for Insulin

Purchase Reports From Reputable Market Research Publishers

USA Insulin Pump Market & Users, CGM (Continuous Glucose Monitoring) Market & Users, Reimbursement Policy (By States), Diabetes (Type1 & 2) Population, Deal Types, Clinical Trials & Forecast

  • $ 1990
  • Industry report
  • August 2017
  • by Renub Research

USA insulin pump market is anticipated to cross US$ 5 Billion by end of the year 2022. Insulin Pump has now become a well-known and a favored device for Type1 diabetes patients in the United States. The ...

InsuLine Medical Ltd (INSL) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2017
  • by GlobalData

Summary InsuLine Medical Ltd (InsuLine Medical) is a medical device company that develops, manufactures and markets device which enables patients on intensive insulin therapy. The company’s products ...

Insulin Pumps - Medical Devices Pipeline Assessment, 2017

  • $ 2500
  • Industry report
  • August 2017
  • by GlobalData

Insulin Pumps - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Insulin Pumps - Medical Devices Pipeline Assessment, 2017" provides an overview of Insulin ...

Artificial Pancreas - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • August 2017
  • by GlobalData

Artificial Pancreas - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Artificial Pancreas - Medical Devices Pipeline Assessment, 2017" provides an overview ...

Novo Nordisk AS (NOVO B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2017
  • by GlobalData

Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious ...

Insulet Corp (PODD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2017
  • by GlobalData

Summary Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes OmniPod insulin management system, an insulin infusion system for diabetic patients. OmniPod insulin ...

Oramed Pharmaceuticals Inc (ORMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2017
  • by GlobalData

Summary Oramed Pharmaceuticals Inc (Oramed) engages in the research and development of novel pharmaceutical solutions, comprising an oral insulin capsule for the treatment of individuals with diabetes, ...

MannKind Corp (MNKD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2017
  • by GlobalData

Summary MannKind Corp (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes. The company’s lead product, Afrezza ...

Diamyd Medical AB (DMYD B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2017
  • by GlobalData

Summary Diamyd Medical AB (Diamyd), formerly Diamyd Therapeutics AB is a drug company that concentrates on the development of therapies for autoimmune diabetes. The company is developing diabetes vaccine, ...

Dance Biopharm Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2017
  • by GlobalData

Summary Dance Biopharm Inc (Dance Biopharm), a subsidiary of Dance Biopharm Holdings Inc, is a biotechnology company that holds expertise in the development of inhaled insulin products to treat diabetes ...

About 9700 reports for Insulin

Download Unlimited Documents from Trusted Public Sources

Insulin Market in the US

  • January 2015
    140 pages
  • Insulin  

    Antidiabetics  

    Therapy  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.